These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22329905)

  • 1. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Maimone D; Gregory S; Arnason BG; Reder AT
    J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.
    Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH
    Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.
    Carrieri PB; Provitera V; De Rosa T; Tartaglia G; Gorga F; Perrella O
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):373-82. PubMed ID: 9736442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.
    Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK
    Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.
    Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
    Eur J Neurol; 2009 Apr; 16(4):528-36. PubMed ID: 19220425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.
    Rossi S; Furlan R; De Chiara V; Motta C; Studer V; Mori F; Musella A; Bergami A; Muzio L; Bernardi G; Battistini L; Martino G; Centonze D
    Ann Neurol; 2012 Jan; 71(1):76-83. PubMed ID: 22275254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
    Mellergård J; Edström M; Vrethem M; Ernerudh J; Dahle C
    Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.
    Vrethem M; Kvarnström M; Stenstam J; Cassel P; Gustafsson M; Landtblom AM; Ernerudh J
    Mult Scler; 2012 May; 18(5):669-73. PubMed ID: 21965416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
    Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
    Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF is up-regulated in central nervous system of neuro-Behçet's disease.
    Hamzaoui K; Houman H; Hentati F; Hamzaoui A
    J Neuroimmunol; 2008 Aug; 200(1-2):111-4. PubMed ID: 18625522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Van Antwerpen MP; Sindic CJ
    Acta Neurol Belg; 1999 Mar; 99(1):11-20. PubMed ID: 10218088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Braitch M; Nunan R; Niepel G; Edwards LJ; Constantinescu CS
    Arch Neurol; 2008 May; 65(5):633-5. PubMed ID: 18474739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Franciotta DM; Grimaldi LM; Martino GV; Piccolo G; Bergamaschi R; Citterio A; Melzi d'Eril GV
    Ann Neurol; 1989 Dec; 26(6):787-9. PubMed ID: 2604386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.